Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
56.3M
-
Shares change
-
-3.02M
-
Total reported value, excl. options
-
$220M
-
Value change
-
-$14.7M
-
Put/Call ratio
-
0.51
-
Number of buys
-
49
-
Number of sells
-
-60
-
Price
-
$3.92
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2021
147 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q4 2021.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.3M shares
of 386M outstanding shares and own 14.58% of the company stock.
Largest 10 shareholders include Indaba Capital Management, L.P. (7.45M shares), BlackRock Inc. (6.25M shares), PRIMECAP MANAGEMENT CO/CA/ (5.09M shares), Neuberger Berman Group LLC (4.2M shares), VANGUARD GROUP INC (3.87M shares), ORBIMED ADVISORS LLC (3.82M shares), NEEDHAM INVESTMENT MANAGEMENT LLC (3.52M shares), BOOTHBAY FUND MANAGEMENT, LLC (2.3M shares), Nuveen Asset Management, LLC (1.96M shares), and STATE STREET CORP (1.47M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.